The study was based on a comparison of AVCS in patients with hypercholesterolemia and a genetically diagnosed familial hypercholesterolemia with a mutation in the low-density lipoprotein receptor gene (LDLR-M) and patients with hypercholesterolemia without the gene mutation (LDLR-WT). The gene discussed is LDLR; the disease is Hypercholesterolemia.